Merit medical announces fda approval of the wrapsody cell-impermeable endoprosthesis

South jordan, utah, dec. 20, 2024 (globe newswire) -- merit medical systems, inc. (nasdaq: mmsi), a leading global manufacturer and marketer of healthcare technology, announced today that the wrapsody® cell-impermeable endoprosthesis has received premarket approval from the us food and drug administration (fda). with this approval, merit can begin commercialization of the device in the usa in 2025.
MMSI Ratings Summary
MMSI Quant Ranking